ScholarIQanswers from OpenAlex & ORCID
Andrea Necchi
ResearcherPublications, citations & collaboration network
Andrea Necchi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andrea Necchi have?
ScholarIQindexed works
Andrea Necchi has 1,303 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andrea Necchi have?
ScholarIQcitation count
Andrea Necchi has 33,885 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andrea Necchi?
ScholarIQh-index
Andrea Necchi has an h-index of 72 in OpenAlex.
What is the i10-index of Andrea Necchi?
ScholarIQi10-index
Andrea Necchi has an i10-index of 368 in OpenAlex.
What is the ORCID of Andrea Necchi?
ScholarIQorcid
The ORCID for Andrea Necchi is on the source record.
What is the OpenAlex record for Andrea Necchi?
ScholarIQopenalex
The OpenAlex for Andrea Necchi is on the source record.
What are the most-cited papers on Andrea Necchi?
ScholarIQmost cited works
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
Joaquim Bellmunt, Ronald de Wit, David J. Vaughn, Yves Fradet, Jae‐Lyun Lee, Lawrence Fong, Nicholas J. Vogelzang, Miguel Ángel Climent, Daniel P. Petrylak, Toni K. Choueiri, Andrea Necchi, Winald R. Gerritsen, Howard Gurney, David I. Quinn, Stéphane Culine, Cora N. Sternberg, Yabing Mai, Christian Poehlein, Rodolfo F. Perini, Dean F. Bajorin
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†
J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, H.M. Bruins, Theo M. de Reijke, Maria De Santis, Silke Gillessen, Nicholas D. James, Steven MacLennan, Juan Palou, Tom Powles, María J. Ribal, Shahrokh F. Shariat, Theodorus van der Kwast, Évanguelos Xylinas, Neeraj Agarwal, Tom J.H. Arends, Aristotle Bamias, Alison Birtle, Peter C. Black, Bernard H. Bochner, M. Bolla, Joost L. Boormans, Alberto Bossi, Alberto Briganti, Iris Brummelhuis, Max M. Burger, Daniel Castellano, Richard Cathomas, Arturo Chiti, Ananya Choudhury, Éva Compérat, Simon J. Crabb, Stéphane Culine, Berardino De Bari, Willem de Blok, Pieter De Visschere, Karel Decaestecker, Konstantinos Dimitropoulos, José L. Domínguez-Escrig, Stefano Fanti, Valérie Fonteyne, Mark Frydenberg, Jurgen J. Fütterer, Georgios Gakis, Bogdan Geavlete, Paolo Gontero, Bernhard Grubmüller, S. Hafeez, Donna E. Hansel, Arndt Hartmann, Dickon Hayne, Ann Henry, Virginia Hernández, Harry W. Herr, Ken Herrmann, Peter Hoskin, J. Huguet, Barbara Alicja Jereczek‐Fossa, Rob Jones, Ashish M. Kamat, Vincent Khoo, Anne E. Kiltie, S. Krege, Sylvain Ladoire, Pedro C. Lara, Anna M. Leliveld, Estefanía Linares-Espinós, Vibeke Løgager, Anja Lorch, Yohann Loriot, Richard P. Meijer, Maria Carmen Mir, Marco Moschini, Hugh Mostafid, Arndt‐Christian Müller, Christoph R. Müller, James N’Dow, Andrea Necchi, Y. Neuzillet, Jorg R. Oddens, Jan Oldenburg, Susanne Osanto, Wim J.G. Oyen, Luís Pacheco‐Figueiredo, Helle Pappot, Manish I. Patel, Bradley R. Pieters, Karin Plass, Mesut Remzi, Margitta Retz, Jonathan Richenberg, Michael Rink, Florian Roghmann, Jonathan E. Rosenberg, Morgan Rouprêt, Olivier Rouvière, Carl Salembier, Antti Salminen, Paul Sargos
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
Daniel P. Petrylak, Ronald de Wit, Kim N., Alexandra Drakaki, Cora N. Sternberg, Hiroyuki Nishiyama, Daniel Castellano, Syed A. Hussain, Aude Fléchon, Aristotelis Bamias, Evan Y. Yu, Michiel S. van der Heijden, Nobuaki Matsubara, B. Yа. Alekseev, Andrea Necchi, Lajos Géczi, Yen‐Chuan Ou, Hasan Şenol Çoşkun, Wen-Pin Su, Miriam Hegemann, Ivor Percent, Jae‐Lyun Lee, Marcello Tucci, Andrey Semenov, Fredrik Laestadius, Avivit Peer, Giampaolo Tortora, Sufia Safina, Xavier García del Muro, Alejo Rodríguez‐Vida, İrfan Çiçin, Hakan Harputluoğlu, Ryan C. Widau, Astra M. Liepa, Richard A. Walgren, Oday Hamid, Annamaria H. Zimmermann, Katherine M. Bell‐McGuinn, Thomas Powles, Suet-Lai Shirley Wong, Thean Hsiang Tan, Elizabeth Hovey, Timothy Clay, Siobhan Ng, Annemie Rutten, Jean‐Pascal Machiels, Herlinde Dumez, Susanna Y. Cheng, Kim Nguyen, Cristiano Ferrario, Lisa Sengeloev, Niels Viggo Jensen, Constance Thibault, Brigitte Laguerre, Fredrik Laestadius, Florence Joly, Aude Fléchon, Stéphane Culine, Catherine Becht, Günter Niegisch, Michael Stöckle, Marc‐Oliver Grimm, Georgios Gakis, Wolfgang Schultze‐Seemann, Haralambos Kalofonos, Dimitriοs Mavroudis, Christos N. Papandreou, Vasilis Karavasilis, Aristotelis Bamias, János Révész, Lajos Géczi, Eli Rosenbaum, Raya Leibowitz‐Amit, Daniel Kejzman, Avivit Peer, David Sarid, Giorgio V. Scagliotti, Cora N. Sternberg, Giampaolo Tortora, Sergio Bracarda, Andrea Necchi, Francesco Massari, Takahiro Osawa, Naoto Miyajima, Nobuo Shinohara, Fumimasa Fukuta, Chikara Οhyama, Wataru Obara, Shinichi Yamashita, Yoshihiko Tomita, Koji Kawai, Satoshi Fukasawa, Nobuaki Matsubara, Masafumi Oyama, Junji Yonese, Masayoshi Nagata, Motohide Uemura, Kazuo Nishimura, Mutsushi Kawakita, Hiroyuki Tsunemori